Maker of Hepatitis C Drug Strikes Deal on Generics for Poor Countries by GARDINER HARRIS

By GARDINER HARRIS

The agreements between Gilead Sciences and seven Indian firms seek to provide treatment to those infected but who do not live in rich countries.

Published: September 16, 2014 at 4:00AM

from NYT Business Day http://ift.tt/ZmsEPM

via IFTTT

from WordPress http://ift.tt/1sWvjeh

via IFTTT